tetrahydropyrimidinone has been researched along with pyrimidinones in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, R; Patel, D | 1 |
| Robert, JM; Sabourin, C | 1 |
| Rai, A; Yadav, LD | 1 |
| Aertgeerts, K; Fujimoto, T; Hiroe, K; Imaeda, Y; Kawamura, M; Konishi, N; Kubo, K; Textor, GP | 1 |
| Kumar, V; Mobin, SM; Nair, VA; Raghavaiah, P | 1 |
| Bretzke, S; Li, P; Menche, D; Morgen, M | 1 |
| Kokotos, CG; Kokotos, G; Limnios, D; Trifonidou, M; Triggidou, D | 1 |
| Ahmadi, H; Bagherzadeh, M; Memarian, HR; Sabzyan, H; Soleymani, M | 1 |
| Sun, J; Yan, CG; Zhang, LL | 1 |
| Abell, L; Adam, LP; Chen, AYA; Finlay, HJ; Galella, M; Gordon, D; Haque, L; Hu, CH; Huang, CS; Li, YX; Onorato, JM; Qiao, JX; Shen, H; Taylor, DS; Toussaint, N; Wang, TC; Wexler, RR; Ying, X | 1 |
10 other study(ies) available for tetrahydropyrimidinone and pyrimidinones
| Article | Year |
|---|---|
Hydrophobicity in the design of P2/P2' tetrahydropyrimidinone HIV protease inhibitors.
Topics: Drug Design; HIV Protease; HIV Protease Inhibitors; Hydrophobic and Hydrophilic Interactions; Ligands; Molecular Conformation; Pyrimidinones; Quantitative Structure-Activity Relationship | 2005 |
Synthesis and immunosuppressive activity evaluation of substituted N-imidazolidin-2-ones and N-tetrahydropyrimidin-2(1H)-ones.
Topics: Animals; Cell Proliferation; Concanavalin A; Imidazolidines; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Pyrimidinones; Spleen; Structure-Activity Relationship | 2008 |
A novel multicomponent synthesis of polyfunctionalized bicyclic tetrahydropyrimidinone derivatives via mercaptoacetylative ring transformations.
Topics: Bridged Bicyclo Compounds; Catalysis; Cyclization; Pyrimidinones; Stereoisomerism | 2009 |
Discovery of a tetrahydropyrimidin-2(1H)-one derivative (TAK-442) as a potent, selective, and orally active factor Xa inhibitor.
Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Bleeding Time; Drug Discovery; Factor Xa Inhibitors; Haplorhini; Humans; Microsomes, Liver; Pharmacokinetics; Pyrimidinones; Rabbits | 2010 |
Diastereoselective syntheses of 3-aryl-5-(arylalkyl)-6-methyl-1-(1-phenylethyl)thioxotetrahydropyrimidin-4(1H)-ones: a stereochemical perspective from endo and exocyclic chiral centres.
Topics: Molecular Structure; Pyrimidinones; Stereoisomerism | 2010 |
Stereodivergent synthesis of 1,3-syn- and -anti-tetrahydropyrimidinones.
Topics: Cyclization; Molecular Structure; Pyrimidinones; Stereoisomerism; Urea | 2010 |
Novel pyrrolidine-thiohydantoins/thioxotetrahydropyrimidinones as highly effective catalysts for the asymmetric Michael addition.
Topics: Catalysis; Molecular Structure; Pyrimidinones; Pyrrolidines; Stereoisomerism; Sulfhydryl Compounds; Thiohydantoins | 2011 |
Voltammetric oxidation of 2-oxo-1,2,3,4-tetrahydropyrimidin-5-carboxamides: substituent effects.
Topics: Acetonitriles; Amides; Biological Products; Carbon; Electrochemistry; Electrodes; Electrons; Isomerism; Models, Chemical; Oxidation-Reduction; Potentiometry; Protons; Pyrimidines; Pyrimidinones | 2011 |
Synthesis of tetrahydropyrimidin-2-ones via FeCl3 catalyzed one-pot domino reaction of amines, methyl propiolate, aromatic aldehydes, and urea.
Topics: Aldehydes; Alkynes; Amines; Catalysis; Chemistry Techniques, Synthetic; Chlorides; Ferric Compounds; Propionates; Pyrimidinones; Urea | 2014 |
Discovery and synthesis of tetrahydropyrimidinedione-4-carboxamides as endothelial lipase inhibitors.
Topics: Animals; Cholesterol, HDL; Enzyme Inhibitors; Humans; Lipase; Mice; Models, Molecular; Pyrimidinones; Structure-Activity Relationship | 2018 |